CD163 and cancer: There is alsoevidence in the litera ture that increased CD163 expression is characteristicof PD-L1+ cancer compared to PD-L1 [23].Our results demonstrate that the CD163+ cell content in tumor stroma positivelycorrelates with PD-L1 expression in stromal but not in tumor cells in GC.